findmyKOL

Razelle Kurzrock, MD

Enriched profile

Center Associate Director; Professor of Medicine (Medical Oncology); Linda T. and John A. Mellowes Endowed Chair of Precision Oncology · Medical College of Wisconsin

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Milwaukee, WI · Midwest · United StatesSpecialtyHematology / OncologyFocusCancer Genomics and Diagnostics+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2022–2026

Razelle Kurzrock is Center Associate Director; Professor of Medicine (Medical Oncology); Linda T. and John A. Mellowes Endowed Chair of Precision Oncology at Medical College of Wisconsin. OpenAlex indexes 2,329 publications with 88,610 citations (h-index 145); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology / Oncology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Razelle Kurzrock, M.D., is Center Associate Director at Medical College of Wisconsin (Froedtert & the Medical College of Wisconsin, Clinical Cancer Center - Froedtert Hospital, Milwaukee, WI). The public record shows 2,329 publications with 88,610 citations (h-index 145), centered on Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2022–2026).

  • Most recent indexed publication: 2026 · Clinical cancer research
  • Top research focus: Cancer Genomics and Diagnostics
  • 18 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)4 trialsLymphoma4 trialsLung Cancer (NSCLC/SCLC)3 trialsMDS / MPN3 trialsColonic Neoplasms3 trialsRectal Neoplasms3 trialsHepatobiliary Cancer3 trialsColorectal Cancer2 trialsLymphoma, T-Cell2 trialsHematologic Neoplasms2 trialsBreast Cancer2 trialsKidney Cancer / RCC2 trialsPancreatic Cancer2 trialsOvarian / Gynecologic Cancer2 trialsMelanoma2 trialsHead & Neck Cancer2 trialsMultiple Myeloma2 trialsSarcoma2 trialsStomach Neoplasms2 trialsUterine Cervical Neoplasms2 trialsLiver Neoplasms2 trialsKidney Neoplasms2 trialsCholangiocarcinoma2 trialsSkin Neoplasms2 trialsTesticular Neoplasms2 trialsAnus Neoplasms2 trialsComa2 trialsAnemia, Refractory1 trialCytopenia1 trialLeukemia, Lymphocytic, Chronic, B-Cell1 trialLymphoma, T-Cell, Cutaneous1 trialLymphoma, T-Cell, Peripheral1 trialLeukemia, Lymphoid1 trialMycosis Fungoides1 trialProstate Cancer1 trialBladder / Urothelial Cancer1 trialGastroesophageal Cancer1 trialNeuro-Oncology / Glioma1 trialLeukemia, Myeloid, Acute1 trialPrecursor Cell Lymphoblastic Leukemia-Lymphoma1 trialEsophageal Neoplasms1 trialHodgkin Disease1 trialFallopian Tube Neoplasms1 trialAstrocytoma1 trialNasopharyngeal Carcinoma1 trialNeuroendocrine Tumors1 trialWaldenstrom Macroglobulinemia1 trialSexually Transmitted Diseases1 trialMesothelioma1 trialLaryngeal Neoplasms1 trialBone Neoplasms1 trialBile Duct Neoplasms1 trialUterine Neoplasms1 trialSalivary Gland Neoplasms1 trialVulvar Neoplasms1 trialLiposarcoma1 trialPheochromocytoma1 trialSarcoma, Kaposi1 trialVaginal Neoplasms1 trialSarcoma, Synovial1 trialTongue Neoplasms1 trialCarcinoid Tumor1 trialNeoplasms, Unknown Primary1 trialPenile Neoplasms1 trialChondrosarcoma1 trialAppendiceal Neoplasms1 trialUreteral Neoplasms1 trialCarcinoma, Adenoid Cystic1 trialParathyroid Neoplasms1 trialAdrenal Gland Neoplasms1 trialCarcinoma, Small Cell1 trialThymus Neoplasms1 trialCysts1 trialMultiple Endocrine Neoplasia1 trialBrain Stem Neoplasms1 trialTrophoblastic Neoplasms1 trialBrain Neoplasms1 trialEndometrial Neoplasms1 trialBiliary Tract Neoplasms1 trialSmall Cell Lung Carcinoma1 trial

Research focus

OpenAlex concept fingerprint
Cancer Genomics and DiagnosticsLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesChronic Lymphocytic Leukemia Research

Drugs & molecules

across trials, industry payments and publications
Enhertugeneric · TrastuzumabClinical trials—Industry payments9Publications2AvelumabClinical trials1Industry payments—Publications1AxitinibClinical trials1Industry payments—Publications1AzacitidineClinical trials1Industry payments—Publications1PalbociclibClinical trials1Industry payments—Publications1Sylvantgeneric · SiltuximabClinical trials—Industry payments4Publications—[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl] 2-[[2-[2-[3-[2,3-bis[2-[2-[[2-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxy]-2-oxoethyl]amino]-2-oxoethoxy]ethoxy]propoxy]-2-[2-[2-[[2-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxy]-2-oxoethyl]amino]-2-oxoethoxy]ethoxy]propoxy]ethoxy]acetyl]amino]acetateClinical trials1Industry payments—Publications—AmifostineClinical trials1Industry payments—Publications—AtiprimodClinical trials1Industry payments—Publications—DarinaparsinClinical trials1Industry payments—Publications—Elzonrisgeneric · TagraxofuspClinical trials—Industry payments1Publications—Halavengeneric · EribulinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
F. Hoffmann-La Roche AGClinical trials—Industry payments13Roche Diagnostics International LtdClinical trials—Industry payments11Daiichi Sankyo Inc.Clinical trials—Industry payments10M.D. Anderson Cancer CenterClinical trials7Industry payments—Recordati_Rare_Diseases_Inc.Clinical trials—Industry payments4Medical College of WisconsinClinical trials3Industry payments—EMD Serono, Inc.Clinical trials—Industry payments2National Cancer Institute (NCI)Clinical trials2Industry payments—Tempus AI, IncClinical trials—Industry payments2Boehringer Ingelheim International GmbHClinical trials—Industry payments1CureOneClinical trials1Industry payments—Eisai Inc.Clinical trials—Industry payments1Enzon Pharmaceuticals, Inc.Clinical trials1Industry payments—GlaxoSmithKline, LLC.Clinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1Roche Diagnostics CorporationClinical trials—Industry payments1Sameem M. Abedin, MDClinical trials1Industry payments—Stemline Therapeutics Inc.Clinical trials—Industry payments1Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments1Taproot HealthClinical trials1Industry payments—TargetCancer FoundationClinical trials1Industry payments—Worldwide Innovative Network AssociationClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,329publications

Distinct works indexed by OpenAlex, matched via ORCID; 124 in PubMed.

88,610citations

Total citations across indexed works.

145h-index

Hirsch index (OpenAlex). i10-index 892.

Clinical & industry

trials, payments and federal funding
18clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2022–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:

All 18 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 20 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:

All 34 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 124 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
    2,392 citations2017
    doi.org ↗
  2. 02
    PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
    2,339 citations2015
    doi.org ↗
  3. 03
    Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
    1,321 citations2008
    doi.org ↗
  4. 04
    The Biology of Chronic Myeloid Leukemia
    1,312 citations1999
    doi.org ↗
  5. 05
    The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
    1,229 citations2020
    doi.org ↗
All 2,329 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

David S. Hong570Aung Naing422Gerald S. Falchook371Jennifer J. Wheler361Apostolia M. Tsimberidou347Siqing Fu334Filip Jankú332Shumei Kato292Sarina A. Piha‐Paul276Funda Meric‐Bernstam196Vivek Subbiah185Moshe Talpaz158Ralph Zinner120Sandip Pravin Patel115Paul T. Fanta114Scott M. Lippman110Jason K. Sicklick103Ryosuke Okamura97Francis J. Giles92Maria Schwaederlé92Aaron M. Goodman92Daniel D. Karp90Young Kwang Chae78Andrés Cervantes78Hagop M. Kantarjian73Suzanna Lee72Megan Othus71Pamela N. Münster71Kenneth R. Hess66Richard B. Lanman66Ignacio Garrido‐Laguna65Sijin Wen65Stacy L. Moulder65Benedito A. Carneiro64Sadakatsu Ikeda63Devalingam Mahalingam62Jordan U. Gutterman62Howard Safran61Vincent A. Miller61Ludimila Cavalcante60

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/razelle-kurzrock-5934757b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Razelle-Kurzrock

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/Dr_R_Kurzrock

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/froedtert.mcw/reel/C5E84JTpWE3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Instagram

    instagram.com/p/DOJ6kuNjdfq

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • Other

    targetcancer.org/team-member/razelle-kurzrock-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetcancer.org ↗
  • Other

    mcw.edu/find-a-doctor/kurzrock-razelle

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • X / Twitter

    X/Twitter: @Dr_R_Kurzrock

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Doctor of Medicine (MD)

    University of Toronto

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • Board Certified

    Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →froedtert.com ↗
  • Board Certified

    Medical Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →froedtert.com ↗
  • FACP - Fellow of the American College of Physicians
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗

Editorial & leadership roles

journal and society appointments
  • Chair

    Early Therapeutics and Rare Cancers Committee, SWOG (NCI cooperative group)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • Editorial Board member

    CA: A Cancer Journal for Clinicians

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acsjournals.onlinelibrary.wiley.com ↗
  • Equal Opportunity and Diversity Officer

    WIN Consortium

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winconsortium.org ↗
  • Principal Investigator

    TargetCancer Foundation TCF-001 TRACK study

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetcancer.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Associate Director of Clinical Research

    MCW Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • Associate Director of Precision Oncology

    Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, MCW

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • Founding Director

    Michels Rare Cancers Research Laboratories, MCW Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcw.edu ↗
  • Chief Medical Officer and Executive Committee member

    WIN Consortium (Worldwide Innovative Network in Personalized Cancer Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winconsortium.org ↗
  • Chief Medical Advisor and Co-Founder

    CureMatch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curematch.com ↗
  • Prior/historical: Distinguished Professor of Medicine

    Director of the Center for Personalized Cancer Therapy and Rare Tumor Clinic, and Associate Director of Clinical Science, Moores Cancer Center …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cdcn.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.